Allergan Plc
(NYSE : AGN)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Generic
symbolcompany%chnglast%shortavg$volume
ZTSZoetis, Inc. 0.96%162.381.9%$235.49m
MYLMylan NV 1.77%14.683.2%$82.93m
TEVATeva Pharmaceutical Industries Ltd. 1.03%8.812.0%$69.18m
RDYDr. Reddy's Laboratories Ltd. -0.68%69.132.0%$12.93m
TXMDTherapeuticsMD, Inc. 1.77%1.4422.1%$3.67m
KINKindred Biosciences, Inc. 3.58%4.630.3%$2.07m
JAGXJaguar Health, Inc. -0.87%0.311.4%$1.79m
COCPCocrystal Pharma, Inc. 1.09%0.930.0%$1.61m
TAROTaro Pharmaceutical Industries Ltd. -0.40%54.586.5%$1.45m
ABEOAbeona Therapeutics, Inc. -38.37%1.154.4%$1.13m
LFVNLifeVantage Corp. 0.97%12.543.3%$0.89m
CPHIChina Pharma Holdings, Inc. 1.35%0.380.1%$0.11m

Company Profile

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.